Literature DB >> 22017011

[The effect of the compatibility of Radix Aconiti Laterlis and radix glycyrrhizae on pharmacokinatic of aconitine, mesaconitine and hypacmitine in rat plasma].

Hong Shen1, Ling-ying Zhu, Nan Yao, Jie Wu.   

Abstract

OBJECTIVE: To established an HPLC-MS assay to determine aconitine, mesaconitine and hypaconitine simultaneously in rat plasma and be used to investigate the pharmacokinetics of the three alkaloids.
METHODS: Three groups of rats were orally administered respectively with three decoctions including decoction of Radix Aconiti Laterlis, blend decoction of Radix Aconiti Laterlis and Radix Glycyrrhizae which decocted separately, decoction of Radix Aconiti Laterlis and Radix Glycyrrhizae which decocted together,the dosage of Radix Aconiti Laterlis was 1.5 g/kg. The contents of aconitine, mesaconitine and hypaconitine in rat plasma were detected using a liquid Chromatography-electrospray ionization/tandem mass spectrometry method. Pharmacokinetic parameters were estimated using DAS 2.0.
RESULTS: The pharmacokinetic parameters of the three compounds obtained showed that Cmax and AUC of aconitine, mesaconitine and hypaconitine were decreased. MRT, t1/2 were prolonged and there was no obviously change in Tmax when Radix Aconiti Lateralis was combined with Radix Glycyrrhizae. The effect of decoction which decocted together was more prominent than which decocted separately.
CONCLUSION: There are obvious effects on pharmacokinetic of Aconitine, Mesaconitine and Hypaconitine in Rat Plasma when Radix Aconiti Laterlis is combined with Radix Glycyrrhizae.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22017011

Source DB:  PubMed          Journal:  Zhong Yao Cai        ISSN: 1001-4454


  3 in total

1.  Effect of processing on the alkaloids in Aconitum tubers by HPLC-TOF/MS.

Authors:  Min Liu; Yan Cao; Diya Lv; Wen Zhang; Zhenyu Zhu; Hai Zhang; Yifeng Chai
Journal:  J Pharm Anal       Date:  2017-01-07

Review 2.  Applications of Network Pharmacology in Traditional Chinese Medicine Research.

Authors:  Zhuchen Zhou; Bing Chen; Simiao Chen; Minqiu Lin; Ying Chen; Shan Jin; Weiyan Chen; Yuyan Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2020-02-14       Impact factor: 2.629

3.  The Pseudotargeted Metabolomics Study on the Toxicity of Fuzi Using Ultraperformance Liquid Chromatography Tandem Mass Spectrometry.

Authors:  Huifei Wu; Wenxia Zhang; Hui Lin; Qiuming Ye; Jiayin Guo; Shijian Quan
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-13       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.